Publications by authors named "Fatimah A Alharbi"
Article Synopsis
- This review analyzes the use of Rituximab (Rmab) as an alternative to cyclophosphamide for treating central nervous system vasculitis (CNSV), highlighting both its benefits and challenges.
- The research follows PRISMA guidelines and examined publications from January 2015 to May 2024, using databases like PubMed and Scopus, resulting in a focused selection of 27 studies.
- Findings suggest that Rmab is effective for inducing remission and maintaining treatment in CNSV patients, leading to lower relapse rates and its growing use in clinical practice.
Background: Although intravenous (IV) thrombolysis is an effective treatment for patients with acute ischemic stroke (AIS), it remains underused by neurologists worldwide. This study assessed the knowledge and attitudes toward IV thrombolysis in patients with AIS among neurology residents in Saudi Arabia.
Materials And Methods: An online survey was conducted using a sample of 81 neurology residents in and around Saudi Arabia.